Drug Assistance Program (ADAP) Emergency Relief Funds (ERF)
🏛 Health Resources and Services Administration (HHS-HRSA)
✓ Free, no account · Source: Grants.gov · Last verified Jul 15, 2026
Can you apply?
This grant is for state and territorial health agencies. Applicants must administer an AIDS Drug Assistance Program (ADAP) or manage ADAP funds. States and U.S. territories with ADAP waiting lists or service gaps are eligible.
The program funds efforts to eliminate waiting lists and fill ADAP shortfalls. Eligible activities include expanding medication access, increasing provider networks, and removing barriers to treatment. Emergency relief funds support urgent gaps in prescription drug assistance.
Applicants must demonstrate an existing ADAP infrastructure and current service delivery challenges. Strong applications show a clear connection between funding requests and specific waiting list reduction or access expansion goals.
Not the right fit? Find grants for your organization in 5 questions →
Key dates
- Jul 13, 2026 Applications open
- Nov 2, 2026 Application deadline in 109 days
- Apr 1, 2027 Award announced
- Apr 1, 2027 Project start
Program description
The purpose of this program is to provide funding to states/territories to prevent, reduce, or eliminate ADAP waiting lists or to address other ADAP shortfalls.
Who can apply
Eligible applicants
Demographic focus
How to apply
Application links
Key dates & requirements
Required documents
- SF-424 (Application for Federal Assistance)
- Project Narrative/Detailed Project Description
- Budget and Budget Narrative
- Proof of ADAP administration status
- Waiting list data and evidence of service shortfalls
Program contact
- 👤 Glenn Clark
- 📧 GLClark@hrsa.gov
- 📞 301.443.3692
Funding track record
Recent awards under CFDA 93.917 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$1,100,139,830
-
$1,013,668,157
-
$947,721,118
-
$927,470,719
-
$520,488,084
-
$355,748,700
-
$287,937,972
-
$284,312,482
-
$256,343,914
-
$251,462,130
Top States by Funding
- CA 3 awards $1,178.7M
- NY 3 awards $1,073.3M
- FL 3 awards $1,026.3M
- TX 3 awards $989.2M
- GA 3 awards $593.9M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 93.917). How funding has trended year over year.
| 2024 | $1,411,488,983 | |
| 2025 | $1,327,748,602 | |
| 2026 est. | $1,327,748,602 |
FAQ
Who is eligible to apply for ADAP Emergency Relief Funds?
State and territorial health agencies administering ADAP programs. Applicants must have existing ADAP operations and documented waiting lists or service shortfalls.
What can these funds be used for?
Preventing, reducing, or eliminating ADAP waiting lists. Funds address critical gaps in medication access and support emergency ADAP shortfalls.
Is cost-sharing required?
No cost-sharing or matching funds are required for this grant.
When is the application deadline?
The deadline is November 2, 2026. This is a fixed deadline, not rolling.
What makes a competitive application?
Strong applications document current waiting lists, explain service gaps clearly, and show how funds will directly reduce barriers to medication access. Include data on program demand and beneficiary populations.
💡 Tips for applicants
- Provide current waiting list data and detailed demographics of individuals awaiting services. Include trend data showing growth or severity of the backlog.
- Connect funding requests directly to elimination timelines. Explain exactly how the grant amount will reduce or eliminate waiting lists.
- Align activities with HRSA's ADAP priorities, including medication access expansion and underserved population outreach.
- Document existing ADAP infrastructure, provider networks, and pharmacy partnerships. Show capacity to deploy funds quickly.
- Include letters of support from ADAP advisory committees or key stakeholders demonstrating community buy-in for your plan.
⚠️ Common mistakes
Applications lack quantified data on waiting lists or underestimate implementation timelines. Vague funding allocation plans without specific activities or benchmarks reduce competitiveness. Failure to address how funds differ from routine ADAP operations weakens emergency relief justification.
Similar grants
- OPEN Ryan White HIV/AIDS Program Part B States/Territories Supplemental Grant Program — Health Resources and Services Administration
- OPEN HIV Care Grant Program – Part B States/Territories Formula and AIDS Drug Assistance Program Formula and AIDS Drug Assistance Program Supplemental Awards — Health Resources and Services Administration
- CLOSED Rapid Response Team (RRT) Cooperative Agreement — Food and Drug Administration
- ROLLING Development and Maintenance of Human and Animal Food Rapid Response Teams (U2F) Clinical Trials Not Allowed — Food and Drug Administration
- OPEN Medication-Assisted Treatment – Prescription Drug and Opioid Addiction — Substance Abuse and Mental Health Services Adminis